Cancer risks in patients with vitiligo: a Mendelian randomization study.

Area of Science:

• Genetics and Immunology
• Oncology
• Dermatology

Background:

• Limited research exists on the link between vitiligo and various cancer risks, particularly non-skin cancers.
• Observational studies face challenges with confounding factors and reverse causation, necessitating robust methodologies.

Purpose of the Study:

• To investigate the causal relationship between vitiligo and the risk of developing different types of cancer.
• To employ a Mendelian randomization approach to overcome limitations of traditional observational studies.

Main Methods:

• Utilized 37 vitiligo-associated single-nucleotide polymorphisms (SNPs) as instrumental variables.
• Analyzed summary data from large-scale genome-wide association studies and cancer consortia, including 246,706 cases and 1,021,154 controls.
• Applied the inverse variance-weighted (IVW) method to estimate causal effects.

Main Results:

• Vitiligo was associated with a reduced risk of lung cancer (OR 0.9513), breast cancer (OR 0.9827), ovarian cancer (OR 0.9474), melanoma (OR 0.9983), non-melanoma skin cancer (OR 0.9997), kidney cancer (OR 0.9998), and liver cancer (OR 0.9999).
• Statistical significance (p < 0.05) was observed for all listed cancer types.
• No significant correlation was found between vitiligo and other cancer types.

Conclusions:

• Vitiligo demonstrates a causal association with decreased risks for several cancers.
• The findings suggest that the autoimmune mechanisms underlying vitiligo may contribute to cancer suppression.